Actively Recruiting

Age: 18Years - 65Years
All Genders
NCT05988879

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

Led by Guangzhou 8th People's Hospital · Updated on 2023-08-14

60

Participants Needed

1

Research Sites

261 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Evaluate the potential of ART combined with interferon therapy to achieve functional cure of hepatitis B in HIV/HBV co-infected patients

CONDITIONS

Official Title

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18-65 years old, gender unrestricted
  • Confirmed HIV-1 infection based on China's AIDS and HIV Infection Diagnostic Criteria
  • Positive hepatitis B surface antigen for more than 6 months
  • At least 1 year of antiretroviral therapy prior to screening
  • Currently on ART with HBsAg <1000 IU/mL, HBeAg negative, HBV DNA <100 IU/mL, CD4+ T lymphocyte count >200 cells/µL, and HIV-RNA <20 copies/mL
Not Eligible

You will not qualify if you...

  • Pregnant, nursing, planning pregnancy, or with severe mental disorders or uncontrolled epilepsy
  • Co-infected with hepatitis A, C, D, or E viruses
  • Having other chronic liver diseases such as autoimmune hepatitis, drug-induced hepatitis, alcoholic hepatitis, genetic metabolic liver diseases, or moderate to severe fatty liver
  • Having autoimmune diseases like rheumatoid arthritis, psoriasis, or lupus
  • Post organ transplant, planning organ transplant, diagnosed or suspected liver cancer or other malignant tumors, or undergoing immunosuppressive treatment
  • Severe diseases of heart, lungs, kidneys, brain, retinal disorders, or uncontrolled hypertension or diabetes
  • Excessive alcohol intake (average daily >40g for men, >20g for women) or drug use
  • Participation in other interventional trials within the last 3 months or other conditions deemed inappropriate by researchers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Guangzhou Eighth People's Hospital, Guangzhou Medical University

Guangzhou, Guangdong, China, 510060

Actively Recruiting

Loading map...

Research Team

L

Linghua Li, PhD

CONTACT

Y

Yaozu He, Master

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here